NJ panel is seeking ways to bring down costs in a dizzying world of rebates, generics, patents, pharmacy benefit managers and more

State and federal authorities have new powers to examine pricing and negotiate for lower costs but there are impediments

Caps on out-of-pocket costs for insulin, EpiPens and asthma inhalers among other measures